GRM Overseas FY26 Revenue Surges 31.4% to ₹1,806 Cr; PAT Up 24.2%
GRM Overseas reported FY26 revenue of ₹1,806 Cr, a 31.4% YoY increase. EBITDA grew 20.2% to ₹127 Cr, and PAT increased 24.2% to ₹76 Cr. Domestic business revenue reached ₹740 Cr, up 37% YoY. The company launched "10X Basmati Rice suitable for Diabetics". International business revenue was ₹854 Cr, up 9% YoY.
The announcement details strong financial performance and strategic product launches, which are material events for investors and stakeholders.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT, along with a successful product launch and strong domestic business performance.
GRM Overseas Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a significant year-on-year increase in total revenue, which grew by 31.4% to ₹1,806 Crores in FY26 from ₹1,374 Crores in FY25. EBITDA for the fiscal year rose by 20.2% to ₹127 Crores from ₹105.6 Crores, and Profit After Tax (PAT) surged by 24.2% to ₹76 Crores from ₹61.2 Crores.
The company's domestic business showed strong momentum, with revenues crossing ₹740 Crores in FY26, a 37% year-on-year increase. In the fourth quarter of FY26 (Q4FY26), the domestic business recorded a revenue of ₹340 Crores. GRM Overseas also launched "10X Basmati Rice suitable for Diabetics" during the quarter, aiming to tap into the growing market for health-oriented food products.
The international business delivered a sustained performance with a 9% year-on-year increase in revenue to ₹854 Crores in FY26. However, performance in Q4FY26 was subdued due to ongoing geopolitical tensions in the Middle East. The company expressed confidence in the future performance of its international business due to expanding presence and diversification.
Mr. Atul Garg, Managing Director, stated, “GRM Overseas has delivered a strong performance in FY26, with Total Revenue growing by 31.4% YoY, driven by increased traction in the domestic business, as well as sustained demand in international markets. EBITDA for the year also registered a 20.2% growth, while margins were largely sustained despite geopolitical hiccups on account of increased scale in the domestic business, as well as GRM’s focus on operational efficiencies.”
What to do with a filing like this
GRM Overseas Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by GRM Overseas Limited. Read the original for the full detail.